Ontology highlight
ABSTRACT:
SUBMITTER: Siska PJ
PROVIDER: S-EPMC5470888 | biostudies-other | 2017 Jun
REPOSITORIES: biostudies-other
Siska Peter J PJ Beckermann Kathryn E KE Mason Frank M FM Andrejeva Gabriela G Greenplate Allison R AR Sendor Adam B AB Chiang Yun-Chen J YJ Corona Armando L AL Gemta Lelisa F LF Vincent Benjamin G BG Wang Richard C RC Kim Bumki B Hong Jiyong J Chen Chiu-Lan CL Bullock Timothy N TN Irish Jonathan M JM Rathmell W Kimryn WK Rathmell Jeffrey C JC
JCI insight 20170615 12
Cancer cells can inhibit effector T cells (Teff) through both immunomodulatory receptors and the impact of cancer metabolism on the tumor microenvironment. Indeed, Teff require high rates of glucose metabolism, and consumption of essential nutrients or generation of waste products by tumor cells may impede essential T cell metabolic pathways. Clear cell renal cell carcinoma (ccRCC) is characterized by loss of the tumor suppressor von Hippel-Lindau (VHL) and altered cancer cell metabolism. Here, ...[more]